Results 201 to 210 of about 2,481 (285)

Type-1 spinal muscular atrophy cohort before and after disease-modifying therapies. [PDF]

Arq Neuropsiquiatr
Alves BKAMF, Araujo APQC, Santos FND, Ribeiro MG.   +3 more
europepmc   +1 more source

A reassessment of spinal cord pathology in severe infantile spinal muscular atrophy: Reassessment of spinal cord pathology. [PDF]

Neuropathol Appl Neurobiol
Allardyce H, Lawrence BD, Crawford TO, Sumner CJ, Parson SH.   +4 more
europepmc   +1 more source

Longitudinal Assessment of 4-Year HFMSE Changes in SMA II and III Patients Treated With Nusinersen. [PDF]

Eur J Neurol
Coratti G, Bovis F, Pane M, Pasternak A, Albamonte E, Mizzoni I, Glanzman AM, Morando S, Montes J, Cavallina I, Dunaway Young S, Duong T, Rolle E, Civitello M, De Sanctis R, Bravetti C, Ricci F, Gadaleta G, Mongini T, Sframeli M, Pera MC, Messina S, D'Amico A, Catteruccia M, Brolatti N, Hirano M, Zolkipli-Cunningham Z, Darras BT, Bertini E, Bruno C, Day J, Sansone VA, Finkel RS, Mercuri E, iSMAC/international SMA consortium.   +34 more
europepmc   +1 more source

Brain magnetic resonance imaging of patients with spinal muscular atrophy type 2 and 3. [PDF]

Neuroimage Clin
Stam M, Tan HHG, Schmidt R, van den Heuvel MP, van den Berg LH, Wadman RI, van der Pol WL.   +6 more
europepmc   +1 more source

Modern Surgery - Chapter 17. Tumors, or Morbid Growths [PDF]

, 1903
Da Costa, John Chalmers
core   +1 more source

Enhancing respiratory function in neuromuscular disease: the role of non-invasive ventilation. A narrative review. [PDF]

Acta Myol
Banfi P, Buscemi AAMD, Compalati E, Pisoni M, Mantero M, Lax A.   +5 more
europepmc   +1 more source

Spinal muscular atrophy: Should we prescribe approved drugs to cohorts of patients in which they are unproven? [PDF]

Eur J Neurol
Fontanelli L, Di Rauso G, Bellini G.
europepmc   +1 more source

Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy. [PDF]

J Neurol
Dobelmann V, Roos A, Hentschel A, Della Marina A, Leo M, Schmitt LI, Maggi L, Schara-Schmidt U, Hagenacker T, Ruck T, Kölbel H.   +10 more
europepmc   +1 more source

The Use of Whole-Body Vibration, Electrical Stimulation, and Magnetic Stimulation in Muscle Dystrophy Patients: A Scoping Review. [PDF]

Cureus
Venieri A, Sarabon N.
europepmc   +1 more source

Risdiplam: therapeutic effects and tolerability in a small cohort of 6 adult type 2 and type 3 SMA patients. [PDF]

Orphanet J Rare Dis
Severa G, Alfaro MDC, Alimi Ichola C, Shoaito H, Souvannanorath S, Authier FJ, Malfatti E.   +6 more
europepmc   +1 more source